Literature DB >> 9088037

Amplification of the c-erbB-2 gene detected by FISH in gastric cancers.

T Sato1, K Abe, A Kurose, N Uesugi, T Todoroki, K Sasaki.   

Abstract

The amplification and overexpression of the c-erbB-2 gene are considered to be implicated in the process of carcinogenesis of a variety of human tumors. The amplification and overexpression of c-erbB-2 were investigated in 48 surgically resected human gastric cancers by means of fluorescence in situ hybridization and immunohistochemistry. DNA ploidy was determined by flow cytometry. The c-erbB-2 amplification was demonstrated as a cluster of signals, suggesting homogeneously staining region (HSR), in three tumors (6.3%) accompanied by the overexpression of its protein. Such overexpression was detected in another tumor without amplification of the c-erbB-2 gene. All tumors with amplification and overexpression of c-erbB-2 were differentiated adenocarcinoma histologically, but only 10.3 and 13.8% of differentiated carcinomas showed amplification and over-expression of the c-erbB-2 gene, respectively. There was no relationship between the amplification and overexpression of c-erbB-2 and the depth of tumor invasion and lymph node involvement. Three of four cases with overexpression of c-erbB-2 were classified into DNA aneuploid tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088037     DOI: 10.1111/j.1440-1827.1997.tb03737.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  1 in total

1.  HER-2/neu amplification is an independent prognostic factor in gastric cancer.

Authors:  Dong Il Park; Jung Won Yun; Jung Ho Park; Suk Joong Oh; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Chang Hak Yoo; Byung Ho Son; Eun Yoon Cho; Seoung Wan Chae; Eo-Jin Kim; Jin Hee Sohn; Seung Ho Ryu; Antonia R Sepulveda
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.